Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Ravani

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
International Journal of Pharmaceutics|April 20, 2012
Long-chain cationic derivatives of PTA (1,3,5-triaza-7-phosphaadamantane) as new components of potential non-viral vectorsRita Cortesi, Paola Bergamini, Laura Ravani, et al.
Materials Science & Engineering. C, Materials for Biological Applications|November 28, 2014
Clotrimazole nanoparticle gel for mucosal administrationElisabetta Esposito, Laura Ravani, Catia Contado, et al.
International Journal of Pharmaceutics|June 25, 2013
Clotrimazole-loaded nanostructured lipid carrier hydrogels: thermal analysis and in vitro studiesLaura Ravani, Elisabetta Esposito, Christian Bories, et al.
The American Journal on Addictions|April 9, 2008
A pilot open-label trial of ropinirole for cocaine dependenceMilo Meini, Barbara Capovani, Alfredo Sbrana, et al.
International Journal of Pharmaceutics|July 19, 2015
Lipid-based nanoparticles containing cationic derivatives of PTA (1,3,5-triaza-7-phosphaadamantane) as innovative vehicle for Pt complexes: Production, characterization and in vitro studiesRita Cortesi, Chiara Damiani, Laura Ravani, et al.
Journal of Pharmaceutical Sciences|December 30, 2009
Evaluation of percutaneous absorption of naproxen from different liposomal formulationsCarmelo Puglia, Francesco Bonina, Luisa Rizza, et al.
International Journal of Pharmaceutics|June 30, 2012
Intranasal immunization in mice with non-ionic surfactants vesicles containing HSV immunogens: a preliminary study as possible vaccine against genital herpesRita Cortesi, Laura Ravani, Francesca Rinaldi, et al.
Addictive Behaviors|June 27, 2006
Reasons for substance use and vulnerability factors in patients with substance use disorder and anxiety or mood disordersJacopo V Bizzarri, Paola Rucci, Alfredo Sbrana, et al.
The American Journal on Addictions|July 7, 2007
Family history of psychiatric disorders and alcohol and substance misuse in patients with bipolar I disorder, substance use disorder, or bothAlfredo Sbrana, Jacopo V Bizzarri, Paola Rucci, et al.
Materials Science & Engineering. C, Materials for Biological Applications|January 13, 2015
Cannabinoid antagonist in nanostructured lipid carriers (NLCs): design, characterization and in vivo studyElisabetta Esposito, Laura Ravani, Markus Drechsler, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
International Journal of Pharmaceutics|April 20, 2012
Long-chain cationic derivatives of PTA (1,3,5-triaza-7-phosphaadamantane) as new components of potential non-viral vectorsRita Cortesi, Paola Bergamini, Laura Ravani, et al.
Materials Science & Engineering. C, Materials for Biological Applications|November 28, 2014
Clotrimazole nanoparticle gel for mucosal administrationElisabetta Esposito, Laura Ravani, Catia Contado, et al.
International Journal of Pharmaceutics|June 25, 2013
Clotrimazole-loaded nanostructured lipid carrier hydrogels: thermal analysis and in vitro studiesLaura Ravani, Elisabetta Esposito, Christian Bories, et al.
The American Journal on Addictions|April 9, 2008
A pilot open-label trial of ropinirole for cocaine dependenceMilo Meini, Barbara Capovani, Alfredo Sbrana, et al.
International Journal of Pharmaceutics|July 19, 2015
Lipid-based nanoparticles containing cationic derivatives of PTA (1,3,5-triaza-7-phosphaadamantane) as innovative vehicle for Pt complexes: Production, characterization and in vitro studiesRita Cortesi, Chiara Damiani, Laura Ravani, et al.
Journal of Pharmaceutical Sciences|December 30, 2009
Evaluation of percutaneous absorption of naproxen from different liposomal formulationsCarmelo Puglia, Francesco Bonina, Luisa Rizza, et al.
International Journal of Pharmaceutics|June 30, 2012
Intranasal immunization in mice with non-ionic surfactants vesicles containing HSV immunogens: a preliminary study as possible vaccine against genital herpesRita Cortesi, Laura Ravani, Francesca Rinaldi, et al.
Addictive Behaviors|June 27, 2006
Reasons for substance use and vulnerability factors in patients with substance use disorder and anxiety or mood disordersJacopo V Bizzarri, Paola Rucci, Alfredo Sbrana, et al.
The American Journal on Addictions|July 7, 2007
Family history of psychiatric disorders and alcohol and substance misuse in patients with bipolar I disorder, substance use disorder, or bothAlfredo Sbrana, Jacopo V Bizzarri, Paola Rucci, et al.
Materials Science & Engineering. C, Materials for Biological Applications|January 13, 2015
Cannabinoid antagonist in nanostructured lipid carriers (NLCs): design, characterization and in vivo studyElisabetta Esposito, Laura Ravani, Markus Drechsler, et al.
Pageof 3